A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 40.62 USD -0.05% Market Closed
Market Cap: 2.4B USD
Have any thoughts about
Apogee Therapeutics Inc?
Write Note

Wall Street
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 95.37 USD with a low forecast of 78.78 USD and a high forecast of 121.8 USD.

Lowest
Price Target
78.78 USD
94% Upside
Average
Price Target
95.37 USD
135% Upside
Highest
Price Target
121.8 USD
200% Upside
Apogee Therapeutics Inc Competitors:
Price Targets
206650
EuBiologics Co Ltd
28% Upside
EDIT
Editas Medicine Inc
153% Upside
300896
Imeik Technology Development Co Ltd
33% Upside
TLX
Telix Pharmaceuticals Ltd
35% Upside
IMMX
Immix Biopharma Inc
247% Upside
TRDA
Entrada Therapeutics Inc
207% Upside
002007
Hualan Biological Engineering Inc
21% Upside
VTVT
vTv Therapeutics Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APGE's stock price target?
Price Target
95.37 USD

According to Wall Street analysts, the average 1-year price target for APGE is 95.37 USD with a low forecast of 78.78 USD and a high forecast of 121.8 USD.

Back to Top